A B S T R A C T Human platelets contain the cuprozinc (cytoplasmic) and manganese (mitochondrial) forms of superoxide dismutase. Nevertheless, superoxide radicals were detectable in the surrounding medium of metabolically viable platelet suspensions by using two assay systems: cytochrome c and nitroblue tetrazolium. The quantity of superoxide generated by platelets (5 x 105 superoxide radicals/platelet per 10 min) was constant and did not increase after aggregation by agents such as collagen and thrombin. The superoxide-generating system was present in the supernate of both aggregated and resting platelets and therefore was not platelet-bound. Platelet superoxide production was unaffected by prior ingestion of aspirin, indicating that the prostaglandin and thromboxane pathways were not involved. Both resting and aggregated platelets exhibited a reductive capacity toward cytochrome c and nitroblue tetrazolium which was unrelated to superoxide production. Furthermore, the aggregation process always resulted in a marked increase in this reduction. The nonsuperoxide reduction associated with aggregation was found to be membrane bound and to decrease with an apparent first order reaction rate (k1 = 0.067 min-'). In addition, accumulative, time-dependent nonsuperoxide-related cytochrome c reduction was also detected. Since there is no superoxide dismutase in plasma, the presence of superoxide radicals in the surrounding medium of platelets may have in vitro significance for platelet and leukocyte concentration and storage and in vivo significance for hemostasis, coagulation, and thrombosis. The nonsuperoxiderelated reducing activities may represent a biochemical basis for platelet-blood vessel interactions, with particular reference to blood vessel integrity.
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INTRODUCTION
Aerobic cells contain the enzyme superoxide dismutase (SOD),1 which serves as protection from destructive effects of superoxide radicals (1, 2) . These free radicals form as toxic intermediates in oxidative metabolic processes because the spin state of oxygen favors univalent pathways of reduction (1) (2) (3) . SOD catalyzes the reaction: O + O2+ 2H->+ 02 + H202. Huiman polymorphontuclear leuikocytes uitilize suiperoxide radicals for bacterial killing (4) (5) (6) , while in the disorder chronic granuloinatous disease, generation of superoxide radicals is defective (6, 7) . Leukocytes also generate°2 in response to cell surface perturbation in the absence of phagocytosis (8, 9) . Superoxide production in lung tissue has been implicated in the pathogenesis of poisoning by the herbicide, paraquat (10) , and in the pulmonary fibrosis resulting from long-term ingestion of nitrofurantoin (11) . Thus, clinical consequences of exposure of cells and tissues to superoxide radicals are becoming apparent.
In the course of an unrelated study involving a lipidprotein fraction from human platelets (12) SOD was identified and an investigation of the role of this enzyme in platelet function was undertaken. Since superoxide radicals are capable of damaging cell membranes and macromolecules (1) (2) (3) , and since there is essentially no SOD in plasma (13) (19) were used for assay. To inhibit cytochrome c oxidase (19) , a potential source of error (20) , KCN (10 ,um) was included in each assay. Manganese SOD was measured by inhibiting the copper-zinc form with 1 mM cyanide (21, 22) . Triton X-100 (0.033%, final concentration) was included in the assays for solubilization of any SOD that may have been particle-bound (23 Platelet SOD was also studied with the use of polyacrylamide gel electrophoresis as described by Beauchamp and Fridovich (20) . However, the resolving gels were chemically polymerized (25) rather than photopolymerized. Samples (100 ug protein) were placed on the gels in Trisglycine buffer containing 20%o glycerol (25) . Gels were stained for SOD activity by the procedure of Salin and McCord (22) .
Assays for 0 generation
Ferricytochrome c (18) and nitroblue tetrazolium (NBT) (6, (26) (27) (28) (31) .
NBT assay. The incubation system was identical to that of the cytochrome c assay (Fig. 1) . A modification of the procedure of Dejesus et al. (28) for measuring NBT reduction by platelets was used. NBT stock solution (0.92 mg/ml in Tyrode salts) was freshly prepared, and after dissolution at 37°C was passed through Whatman no. 1 filter paper. The pH was readjusted to 7.35 with 5% CO2 gas. Final concentrations in the incubation mixture were: NBT, 0.4 mg/ml, and SOD, 8.2 ,ug/ml. Unless otherwise indicated, 40 Mug of collagen was added to induce aggregation. Assays were initiated by addition of0.5 ml platelet suspension to the other reactants, which were not prewarmed. Total volume of incubation mixtures was 1.15 ml. Incubations (20 min in most experiments) were terminated by addition of 5 ml 0.5 N HCl, vortex mixing, and placement in ice. The tubes were centrifuged at 3,500 g for 45 min (4QC), supernates discarded, and sediments overlayed with 1 ml pyridine. After storage overnight (4°C), the sediments were broken up with glass rods and the tubes capped 3Kindly provided by Dr Other procedures. Radioactive serotonin uptake and release were measured by the technique of Valdorf-Hansen and Zucker (32) . Protein determinations were as previously described (19) .
RESULTS
Platelet SOD. The cuprozinc and manganese forms of SOD were detectable in whole platelets. Frozen and thawed platelets, pooled from several donors, contained superoxide dismutase equivalent to lfg of bovine erythrocyte SOD/platelet. About 13% of the enzyme activity was cyanide-insensitive, indicating the presence of manganese (mitochondrial) SOD (21, 33) . Assays carried out on the soluble fraction derived from an ultracentrifuged platelet homogenate (19) Fig. 3 . Properties of platelet suspensions. Experiments could not be conducted in platelet-rich plasma since there was interference by plasma components in both the cytochrome c and NBT assays. Furthermore, the number of platelets in platelet-rich plasma was below the sensitivity range of the detection systems. Thus it was necessary to carry out the studies in a washed platelet system (15) . The pH was stable over the course of the experiments (average change, 0.2 U) and [14C]serotonin uptake averaged 90% during that time, indicating that the platelets were metabolically viable (17) . Oxygen consumption was intact, as monitored by a Clark electrode (model 53, Yellow Springs Instrument Co., Yellow Springs, Ohio). Aggregation responses to collagen and thrombin were maximal throughout the test period and were preceded by a shape change.
Superoxide detection by cytochrome c assay.°2 radicals were detected in the surrounding medium of unstimulated and collagen-aggregated platelets in each of 15 experiments. The quantity of°2 detected did not change with the age of the platelet suspension, nor was there a significant difference between aggregated and nonaggregated platelets (Table  I) . A prominent feature of all experiments was nonsuperoxide-related cytochrome c reduction. This reduction, which was not inhibitable by SOD, was detected in nonaggregated as well as aggregated platelet incubates and increased with the age of the platelet suspension. Furthermore, when the platelets were removed from the system at successive time intervals by centrifugation, the increase in non-O0 reducing capacity was detectable in the supernates. That portion of the non-02 reducing capacity which is present in the supernate is responsible for the slope of the curves shown in Figs. 4 and 5. The substance (s) responsible for this time-dependent cytochrome c reduction was not identified. Reduced glutathione was not detected (34) in the supernate and addition of a quantity of serotonin which would be expected to be released from 1 x 109 platelets did not reduce cytochrome c.
In addition to the time-dependent non-02 cytochrome c reduction described above, a marked increase in non-O reduction always occurred in association with the aggregation process. The elevated position of the two curves representing aggregated platelets (Fig. 4) is due to this increase in reduction. The association of the increase in nonsuperoxiderelated reduction with aggregation was further explored. The cytochrome c assay was carried out in an aggregometer and the reaction terminated at the upswing of the recorded collagen-induced aggregation curve (31 s) . Under this circumstance the increase in non-02-related reduction was absent. In contrast, when the reaction was terminated in 115 s (irreversible aggregation) the increase in non-02-related reduction was present. This phenomenon was demonstrable clinically when platelets from a donor who had ingested medication containing glyceryl guaiacolate (35) showed a negligible aggregation response to collagen.4 In the absence of macroscopic aggregation, the increase in non-02-related reduction did not occur. Nevertheless, superoxide production itself was detected in collagen-treated and -untreated platelet sus- 4 Scattered microscopic aggregates were observed by phase contrast.
pensions. It can be seen in Fig. 5 that the points obtained with collagen-treated and 'resting' platelets were virtually superimposable.
Since thrombin stimulates platelets by a mechanism different from that of collagen (36) , experiments on thrombin-induced aggregation were performed. The results obtained were identical to those observed with collagen.
As agitation is required for platelet aggregation, the effect of shaking in the absence of an aggregating agent was evaluated. Results of these experiments indicated that platelet motion was not the determinant of°2 generation or total cytochrome c reduction.
When autoclaved SOD was used in place ofthe active enzyme there was no difference in cytochrome c reduction between reaction mixtures containing the autoclaved preparation and those containing no enzyme. This eliminates the possibility of a nonspecific inhibitory effect related to the presence of protein in the assay.
Superoxide detection by NBT assay. This system was used for confirmation and extension of results obtained with cytochrome c assays. A major difference between the NBT and cytochrome c results was the absence of interference by time-dependent non-°2
reduction. This enabled us to carry out experiments at convenient time intervals without correlating results with the age of the platelet suspension. Superoxide radicals were detected in aggregated and 'resting' platelets in 15 separate experiments. Non-02-related NBT reduction was present in unstimulated platelets and, as in the cytochrome system, aggregation was accompanied by a significant increase in such reduction (Fig. 6 ). NBT reduction after aspirin ingestion. Superoxide-and nonsuperoxide-related NBT reduction was studied with the platelets of a donor who had ingested four 300-mg tablets of acetylsalicylic acid 24 h previously. Aggregation responses to varying concentrations of collagen and their effect on NBT reduction were evaluated. As shown in Fig. 7 , aspirin ingestion had no effect on superoxide production in 'resting' or stimulated platelets. When low concentrations of collagen were used, aggregation and [I4C]serotonin release did not take place and the increase in non-O--related reduction was also absent. At higher collagen concentrations the inhibitory effect ofaspirin was overcome, aggregation and release occurred, and the increase in non-O NBT reduction was apparent. Thus it can be concluded that superoxide production by platelets does not appear to be dependent upon the prostaglandin and thromboxane pathways (37) since it wvas not inhibited after aspirin ingestion.
Presence of leukocytes in platelet suspensions. Granulocytes and monocytes were essentially absent from the final platelet suspensions. The only contaminating cells seen on stained smears were lymphocytes, which do not generate superoxide radicals (38, 39 ). An additional experiment was carried out in which leukocyte contamination was reduced further. Only the upper 60% of the platelet-rich plasma layer in the blood bag was processed. This plasma was respun at 100 g and the supernatant platelets processed further. production, which was constant and equal in aggregated and nonaggregated platelets.
Experiments were carried out to determine whether the systems responsible for superoxide-as well as nonsuperoxide-related reduction associated with aggregation were platelet-bound or free in the supernate. Collagen-stimulated platelets were incubated in buffer (12 min) in the absence of NBT, followed by placement in ice (10 min) and centrifugation at 3,000 rpm for 20 min (4°C). The supernates were stored in ice (1-3 h) until all test samples and controls were prepared. Aliquots derived from 1 x 109 platelets were then added to the standard NBT assay. As shown in Table III , the non-0 NBT reduction was plateletbound, but the superoxide-generating mechanism was present in the supernate. These results will be analyzed in detail in the Discussion.
The relationship of physical platelet aggregation to the non-O reduction associated with the aggregation process was studied by inhibiting gross and microscopic thrombin-induced aggregation with EDTA. NBT reduction and ['4C]serotonin release were measured in the usual manner. The results are shown in Table IV , where it can be seen that stimulated but unaggregated platelets were still capable of eliciting 54% of the increase in non-O reduction achieved in the control samples. Concomitantly, release in the presence of EDTA was 62% of that in the aggregated control. Table IV also shows that the presence of EDTA had no effect on the production of superoxide radicals. It is therefore apparent that the events leading to full platelet aggregation, including release, are required for the non-0Q reducing activity associated with the aggregation process.
DISCUSSION
Human platelets cointain 1 fg SOD/platelet,5 which is approximately one-fifth of that present in the leukocyte (22) and one-ninth of that in the erythrocyte (13) . Approximately 13% of platelet SOD is the manganese-dependent form located in mitochondria (2) . The latter finding favors previous contentions that mitochondrial metabolism plays an important role in platelet function (36, 40) .
Fridovich has proposed that the univalent reduction of oxygen accounts for a constant fraction of the total oxygen reducing capacity of all cells (2) . The SOD in each cell should dismutate all of the°2 formed. Therefore, no 02 should be expected to appear extracellularly. However, in the case of stimulated leukocytes, superoxide radicals are detectable in the external environment of the cells (4, 22 (13) . It was therefore pertinent to determine whether superoxide radicals were present in the extracellular medium of human platelets.
The results of cytochrome c and NBT assays demonstrated that superoxide production was detectable in aggregated and unaggregated platelets. Analysis of the data indicated that the quantities of 02 produced (5 x 105 02 radicals/platelet per 10 min) in aggregated (Table II) were designed to test the following hypotheses: in response to stimulation by an aggregating agent platelets produce 0°radicals in a 'burst' and no additional 0°there-after. In contrast unaggregated platelet suspensions generate 0°continuously. Thus under certain experimental conditions an 'apparently' equal production of 0°by aggregated and unaggregated platelets might be detected. The results of these experiments indicated that aggregating platelets did not produce superoxide in a 'burst.' If a 'burst' of°2 had occurred it would have been undetectable when NBT was added 5 or 12 min later, since superoxide radicals dismutate in a matter of seconds (46) . It was therefore confirmed that the rate of°2 production in aggregated and resting platelets is constant.
With regard to the electron source for the formation of the superoxide radical, one can postulate a system whereby a substance 'Sred' is produced by platelets and univalently reduces molecular oxygen to 02.
In the process 'Sred' is oxidized to 'SOxid.' Since the amount of 0°detected by a 20-min incubation with NBT commencing at any time in the course of an experiment was constant (Tables I and II, Figs. 4 and 5) , it follows that there exists a small, steady-state concentration of 'Sred.' If 'Sred' were released by the platelets into the medium, it should be possible to detect 0°production even after removal of the platelets. Assays of the supernates of stimulated and unstimulated platelets revealed that as much as 25% of the superoxide radicals of the uncentrifuged controls were detected in the supernates (Table III) . It is to be expected that the 0°generated by the platelet suspensions during the preincubation period before the time of supernatant separation would not be detected by the NBT assay, since it would have rapidly dismutated. What (47) reported that externally generated. 0°, in concentrations insufficient to aggregate platelets, did so synergistically in the presence of subthreshold quantities of thrombin.
As (Table III) shows that 12 min after collagen stimulation we obtained an OD 515 nm value of 0.002. If 'A' had remained in the supernate, the OD should have been 45% of the control value, i.e., 0.028 (Table II,  columns 4 and 5 ). An alternative possibility is that 'A' was indeed released into the supernate by the aggregating platelets but was completely oxidized at 40C. However, in experiments not shown it was noted that non-O-related reduction does not proceed in the cold. We thus postulate that the increased nonsuperoxide reduction elicited by platelet stimulation is plateletbound. This membrane-associated transient reducing capacity may be due to platelet membrane sulfhydryl groups (48) , whose spatial orientation is altered during the events leading to aggregation. The reduction may be membrane enzyme-mediated, as proposed by Baehner et al. (27, 49) for phagocytizing leukocytes.
Since this reduction represents a surface alteration which was not present before the aggregation process, further biochemical and physical studies of the events responsible for this phenomenon may provide new insights into the role of the platelet membrane in platelet function. Finally, one could speculate about possible involvement of the process in platelet-blood vessel interactions, with particular reference to the maintenance of blood vessel integrity.
There are now reports in the literature concerning the use of SOD for therapeutic purposes (50) (51) (52) . On the basis of current in vitro (53, 54) and in vivo (55) data, it can be speculated that inclusion of SOD in platelet and leukocyte concentrates would dismutate accumulating superoxide radicals and thereby prolong the functional capabilities of these components in the circulation of bleeding and (or) infected patients.
